Association of hypophosphatemia-occurring sorafenib with prognosis and hepatic impairment in patients with advanced hepatocellular carcinoma. Background: Intraductal papillary mucinous neoplasm (IPMN) ...

PARIS, France — Fewer than 1% of patients with intraductal papillary mucinous neoplasms (IPMNs) of the branch ducts develop adenocarcinoma after 5 years of follow-up monitoring, according to a French ...

(SALT LAKE CITY)—Cancer of the pancreas is usually not detected until it's too late to cure. But precursor lesions that form in the pancreas and its ducts can signal the disease before it strikes, and ...

A research team at Duke Health has identified a set of biomarkers that could help to distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. The team carried out ...

Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 This international ...

A research team has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. A research team at Duke Health has ...

Researchers have outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. The findings could reveal the mechanism of ...